Table GPS-8. Lifetime prevalence of drug use among all adults (aged 15 to 64 years) in nationwide surveys among the general population. [see all tables in this series...]

Part (i) Lifetime prevalence all adults: last survey available for each Member State (from 2000 onwards)

Country		Geographical area	Year	Reference	Age range all adults	Sample size all adults	Cannabis (%)	Cocaine (%) (1)	Amphetamines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium		National	2004	(6)	15–64		13
Bulgaria		National	2005	(1)	18–60	1036	4.4	1.1	1.4	1.3	0.8
Czech Republic		National	2004	(2)	18–64	3526	20.6	1.1	2.5	7.1	1.4
Denmark		National	2005	(4)	16–64	13310	36.5	4	6.9	1.8	1.7
Germany		National	2006	(7)	18–64	7912	23	2.5	2.5	2	1.7
Estonia		National	2003	(2)
Ireland		National	2006–07	(5)	15–64	4967	21.9	5.3	3.5	5.4	2.9
Greece		National (except Aegean and Ionian Islands)	2004	(3)	15–64	4351	8.9	0.7	0.1	0.4	0.3
Spain		National	2005–06	(6)	15–64	27934	28.6	7	3.4	4.4
France		National	2005	(6)	15–64	25879	30.6	2.6	1.4	2	1.5
Italy		National	2005	(3)	15–64	27995	29.3	6.6	2.4	2.5	3.1
Cyprus		National	2006	(1)	15–64	3504	6.6	1.1	0.8	1.6	0.9
Latvia		National	2003	(1)	15–64	4534	10.6	1.2	2.6	2.4	1.1
Lithuania		National	2004	(1)	15–64	4207	7.6	0.4	1.1	1	0.3
Hungary		National	2003	(2)	18–54		9.8	1	2.5	3.1	1.7
Malta		National	2001	(1)	18–64	1755	3.5	0.4	0.4	0.7	0.5
Netherlands		National	2005	(3)	15–64	4516	22.6	3.4	2.1	4.3	1.4
Austria		National	2004	(1)	15–64	3980	20.1	2.3	2.4	3	1.7
Poland		National	2006	(2)	15–64	2859	9	0.8	2.7	1.2	0.9
Portugal		National	2007	(2)	15–64	12202	11.7	1.9	0.9	1.3	0.6
Romania		National	2004	(1)	15–64		1.7	0.4	0.2	0.3	0.2
Slovakia		National	2006	(6)	15–64	1305	16.1	1.2	1.2	4.3
Finland		National	2006	(7)	15–64	2802	14.3	1.1	2.2	1.6	1.1
Sweden		National	2006	(7)	16–64	41701	12
United Kingdom		England and Wales	2006–07	(10)	16–59	31054	30.1	7.7	11.9	7.3	5.4
United Kingdom		Northern Ireland	2005	(12)	16–59		18.9	3.9	6.6	5.9	3.2
United Kingdom		Scotland	2006	(15)	16–59	3157	32.9	8.9	14.1	9.9	7.7
United Kingdom		United Kingdom	2004	(13)			29.6	6.5	11.7	6.7	5.9
Norway		National	2004	(2)	15–64	2669	16.2	2.7	3.6	1.8	1.1

Notes:

 This table presents the methods and results for the last surveys available in each country. The number indicated in the ‘Ref.’ column is the reference to the corresponding survey in the table presenting all surveys available for each country in Table GPS-1. For sources of each survey see Table GPS-0. 

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy. 

 (3) For Spain: ecstasy and other designer drugs. 

 This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 

 For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 See Table GPS-0. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)